| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 24 | 2023 | 339 | 6.090 |
Why?
|
| Lung Neoplasms | 39 | 2024 | 1612 | 5.900 |
Why?
|
| Esophageal Neoplasms | 15 | 2024 | 356 | 4.270 |
Why?
|
| Mesothelioma | 7 | 2022 | 80 | 3.350 |
Why?
|
| Pneumonectomy | 15 | 2022 | 140 | 3.100 |
Why?
|
| Esophagectomy | 10 | 2024 | 64 | 2.720 |
Why?
|
| Adenocarcinoma | 12 | 2024 | 1003 | 2.400 |
Why?
|
| Neoplasm Staging | 29 | 2023 | 1223 | 2.260 |
Why?
|
| Pleural Neoplasms | 5 | 2022 | 65 | 1.760 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2023 | 34 | 1.690 |
Why?
|
| Lymphatic Metastasis | 14 | 2024 | 398 | 1.680 |
Why?
|
| Thoracic Surgical Procedures | 4 | 2020 | 102 | 1.540 |
Why?
|
| Lymph Nodes | 10 | 2017 | 379 | 1.410 |
Why?
|
| Neoadjuvant Therapy | 6 | 2022 | 328 | 1.330 |
Why?
|
| Esophageal Perforation | 4 | 2024 | 14 | 1.240 |
Why?
|
| Thoracoscopy | 4 | 2021 | 42 | 0.970 |
Why?
|
| Surgical Flaps | 3 | 2021 | 204 | 0.950 |
Why?
|
| SEER Program | 8 | 2019 | 192 | 0.900 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2023 | 370 | 0.900 |
Why?
|
| Radiosurgery | 2 | 2022 | 109 | 0.870 |
Why?
|
| Neoplasm Grading | 2 | 2023 | 266 | 0.860 |
Why?
|
| Humans | 104 | 2024 | 121045 | 0.820 |
Why?
|
| Bronchial Fistula | 4 | 2012 | 21 | 0.790 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 284 | 0.780 |
Why?
|
| Endosonography | 4 | 2012 | 84 | 0.770 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2011 | 97 | 0.770 |
Why?
|
| Pleural Diseases | 3 | 2009 | 27 | 0.770 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2012 | 111 | 0.760 |
Why?
|
| Funnel Chest | 1 | 2021 | 34 | 0.730 |
Why?
|
| Metastasectomy | 1 | 2020 | 11 | 0.730 |
Why?
|
| Respiratory Paralysis | 2 | 2010 | 7 | 0.710 |
Why?
|
| Ketorolac | 1 | 2020 | 17 | 0.690 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2019 | 68 | 0.630 |
Why?
|
| Stomach | 1 | 2021 | 266 | 0.620 |
Why?
|
| Databases, Factual | 3 | 2019 | 1137 | 0.620 |
Why?
|
| Treatment Outcome | 25 | 2022 | 11680 | 0.610 |
Why?
|
| Health Services Research | 1 | 2019 | 182 | 0.610 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2021 | 1107 | 0.600 |
Why?
|
| Surgeons | 3 | 2021 | 245 | 0.600 |
Why?
|
| Internship and Residency | 5 | 2021 | 1152 | 0.590 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 180 | 0.590 |
Why?
|
| Educational Measurement | 2 | 2020 | 319 | 0.590 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 161 | 0.560 |
Why?
|
| Frailty | 1 | 2019 | 97 | 0.560 |
Why?
|
| Certification | 1 | 2017 | 69 | 0.550 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 99 | 0.550 |
Why?
|
| Registries | 3 | 2019 | 1336 | 0.540 |
Why?
|
| Respiratory Function Tests | 10 | 2010 | 193 | 0.520 |
Why?
|
| Thoracic Surgery | 5 | 2019 | 157 | 0.490 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 649 | 0.480 |
Why?
|
| Postoperative Care | 3 | 2016 | 293 | 0.480 |
Why?
|
| Middle Aged | 48 | 2020 | 25263 | 0.470 |
Why?
|
| Mediastinum | 9 | 2012 | 41 | 0.470 |
Why?
|
| Laparoscopy | 4 | 2020 | 507 | 0.460 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 29 | 0.450 |
Why?
|
| Aged | 38 | 2020 | 18399 | 0.440 |
Why?
|
| Mediastinoscopy | 3 | 2009 | 5 | 0.440 |
Why?
|
| Survival Rate | 13 | 2022 | 1973 | 0.440 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 590 | 0.430 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 836 | 0.420 |
Why?
|
| Aged, 80 and over | 22 | 2020 | 6091 | 0.410 |
Why?
|
| Prognosis | 8 | 2024 | 4472 | 0.410 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1086 | 0.410 |
Why?
|
| Lung | 8 | 2022 | 1461 | 0.410 |
Why?
|
| Retrospective Studies | 28 | 2022 | 15563 | 0.400 |
Why?
|
| Insurance, Health | 1 | 2013 | 133 | 0.400 |
Why?
|
| Insurance Coverage | 1 | 2013 | 121 | 0.390 |
Why?
|
| Ultrasonography, Interventional | 3 | 2016 | 194 | 0.380 |
Why?
|
| Cisplatin | 4 | 2023 | 256 | 0.380 |
Why?
|
| Postoperative Complications | 8 | 2016 | 2869 | 0.380 |
Why?
|
| Smoking | 7 | 2008 | 1021 | 0.380 |
Why?
|
| Drainage | 6 | 2016 | 250 | 0.380 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 21 | 0.370 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 15 | 0.370 |
Why?
|
| Esophagoscopy | 4 | 2024 | 150 | 0.360 |
Why?
|
| Male | 53 | 2021 | 58908 | 0.360 |
Why?
|
| Colectomy | 1 | 2011 | 75 | 0.360 |
Why?
|
| Thoracic Neoplasms | 1 | 2010 | 38 | 0.350 |
Why?
|
| Appendectomy | 1 | 2011 | 96 | 0.350 |
Why?
|
| Risk Factors | 9 | 2024 | 9603 | 0.350 |
Why?
|
| Diaphragmatic Eventration | 1 | 2009 | 7 | 0.350 |
Why?
|
| Anastomosis, Surgical | 2 | 2021 | 167 | 0.340 |
Why?
|
| Respiratory Tract Fistula | 1 | 2009 | 16 | 0.340 |
Why?
|
| Diaphragm | 1 | 2010 | 97 | 0.330 |
Why?
|
| Melanoma | 2 | 2013 | 839 | 0.320 |
Why?
|
| Thymus Neoplasms | 2 | 2019 | 39 | 0.320 |
Why?
|
| Female | 49 | 2021 | 63993 | 0.310 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 40 | 0.310 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2008 | 9 | 0.300 |
Why?
|
| Risk Assessment | 8 | 2021 | 3200 | 0.290 |
Why?
|
| Health Status Disparities | 1 | 2010 | 212 | 0.290 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 230 | 0.290 |
Why?
|
| Clinical Competence | 3 | 2015 | 966 | 0.280 |
Why?
|
| Device Removal | 2 | 2010 | 219 | 0.280 |
Why?
|
| Quality of Life | 4 | 2022 | 1891 | 0.270 |
Why?
|
| Neoplasms | 1 | 2021 | 2729 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 1977 | 0.270 |
Why?
|
| Predictive Value of Tests | 5 | 2023 | 2055 | 0.260 |
Why?
|
| United States | 12 | 2021 | 10332 | 0.260 |
Why?
|
| Reoperation | 4 | 2021 | 772 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 398 | 0.250 |
Why?
|
| Adult | 34 | 2021 | 28363 | 0.250 |
Why?
|
| Chemoradiotherapy, Adjuvant | 2 | 2018 | 28 | 0.250 |
Why?
|
| Career Choice | 2 | 2015 | 143 | 0.230 |
Why?
|
| Time Factors | 12 | 2018 | 5975 | 0.230 |
Why?
|
| Cytoreduction Surgical Procedures | 2 | 2022 | 32 | 0.230 |
Why?
|
| Hospitals, High-Volume | 2 | 2021 | 32 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 925 | 0.220 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2021 | 72 | 0.210 |
Why?
|
| Patient Selection | 4 | 2015 | 645 | 0.210 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 1806 | 0.200 |
Why?
|
| Thoracic Surgery, Video-Assisted | 4 | 2009 | 55 | 0.190 |
Why?
|
| Sternum | 1 | 2021 | 53 | 0.190 |
Why?
|
| Heart Transplantation | 1 | 2008 | 856 | 0.190 |
Why?
|
| Survival Analysis | 5 | 2017 | 1454 | 0.190 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 12 | 0.180 |
Why?
|
| Myotomy | 1 | 2020 | 17 | 0.180 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 569 | 0.180 |
Why?
|
| Respiration | 4 | 1990 | 123 | 0.180 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 205 | 0.180 |
Why?
|
| Surveys and Questionnaires | 5 | 2015 | 3596 | 0.170 |
Why?
|
| Thymectomy | 1 | 2019 | 24 | 0.160 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 11 | 0.160 |
Why?
|
| Thymoma | 1 | 2019 | 17 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 86 | 0.160 |
Why?
|
| Margins of Excision | 1 | 2019 | 51 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 78 | 0.160 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 1022 | 0.160 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2019 | 40 | 0.160 |
Why?
|
| Attention | 1 | 2020 | 194 | 0.160 |
Why?
|
| Intention | 1 | 2019 | 93 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1243 | 0.150 |
Why?
|
| Pneumothorax | 2 | 2009 | 80 | 0.150 |
Why?
|
| Thoracotomy | 2 | 2008 | 111 | 0.150 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 4957 | 0.150 |
Why?
|
| Robotics | 1 | 2019 | 110 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3403 | 0.140 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 95 | 0.140 |
Why?
|
| Tumor Burden | 2 | 2015 | 230 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 124 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2019 | 302 | 0.140 |
Why?
|
| Lymph Node Excision | 3 | 2012 | 157 | 0.140 |
Why?
|
| Population Surveillance | 2 | 2016 | 364 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 88 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2011 | 974 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1923 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2016 | 132 | 0.130 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2015 | 10 | 0.130 |
Why?
|
| Esophagogastric Junction | 2 | 2020 | 26 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 597 | 0.130 |
Why?
|
| Respiration Disorders | 1 | 2015 | 31 | 0.130 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2011 | 11 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 607 | 0.120 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1994 | 2 | 0.120 |
Why?
|
| Bronchoscopy | 3 | 2010 | 153 | 0.120 |
Why?
|
| Mucociliary Clearance | 1 | 1994 | 4 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 1999 | 0.120 |
Why?
|
| Stomach Neoplasms | 2 | 2012 | 537 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2022 | 4577 | 0.120 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 75 | 0.120 |
Why?
|
| Morbidity | 1 | 2015 | 236 | 0.120 |
Why?
|
| Endoscopy | 1 | 2016 | 278 | 0.120 |
Why?
|
| Probability | 3 | 2009 | 318 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2013 | 1215 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2013 | 272 | 0.110 |
Why?
|
| Empyema, Pleural | 2 | 2009 | 23 | 0.110 |
Why?
|
| Esophageal Fistula | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bronchi | 1 | 2012 | 99 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 8627 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2016 | 334 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2297 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 6 | 2008 | 50 | 0.100 |
Why?
|
| Disease Management | 1 | 2015 | 512 | 0.090 |
Why?
|
| Emergencies | 1 | 2012 | 172 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2010 | 932 | 0.090 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2010 | 13 | 0.090 |
Why?
|
| Incidence | 2 | 2008 | 2965 | 0.090 |
Why?
|
| Pharyngostomy | 1 | 2010 | 2 | 0.090 |
Why?
|
| Medicaid | 1 | 2013 | 238 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2010 | 37 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 505 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 220 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 52 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1418 | 0.090 |
Why?
|
| Rheumatoid Nodule | 1 | 2009 | 2 | 0.090 |
Why?
|
| Cervical Vertebrae | 1 | 2010 | 104 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 66 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2012 | 976 | 0.080 |
Why?
|
| Carcinoma | 1 | 2012 | 281 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 94 | 0.080 |
Why?
|
| Stents | 2 | 2012 | 684 | 0.080 |
Why?
|
| Medicare | 1 | 2013 | 417 | 0.080 |
Why?
|
| Cardia | 1 | 2009 | 27 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2009 | 23 | 0.080 |
Why?
|
| Fistula | 1 | 2009 | 50 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 6 | 0.080 |
Why?
|
| Abdominal Abscess | 1 | 2009 | 24 | 0.080 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 9 | 0.080 |
Why?
|
| Esophagus | 1 | 2010 | 207 | 0.080 |
Why?
|
| Physicians | 1 | 2015 | 580 | 0.080 |
Why?
|
| Talc | 1 | 1988 | 1 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2009 | 97 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 181 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2009 | 199 | 0.080 |
Why?
|
| Disease-Free Survival | 4 | 2011 | 865 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 205 | 0.070 |
Why?
|
| Fibrosis | 1 | 2009 | 422 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 77 | 0.070 |
Why?
|
| Carcinosarcoma | 1 | 2007 | 10 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 137 | 0.070 |
Why?
|
| Radiography | 1 | 2009 | 798 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 123 | 0.070 |
Why?
|
| Adolescent | 5 | 2019 | 18730 | 0.070 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2006 | 13 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2008 | 188 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2010 | 383 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2006 | 63 | 0.070 |
Why?
|
| Minnesota | 3 | 2011 | 95 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 252 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 1023 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2007 | 117 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 234 | 0.060 |
Why?
|
| General Surgery | 1 | 2008 | 204 | 0.060 |
Why?
|
| Equipment Design | 1 | 2008 | 586 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 404 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 237 | 0.060 |
Why?
|
| Reference Values | 3 | 2009 | 693 | 0.060 |
Why?
|
| Comorbidity | 3 | 2016 | 1472 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 424 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 807 | 0.060 |
Why?
|
| Age Factors | 4 | 2012 | 2760 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 1284 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 1258 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 798 | 0.050 |
Why?
|
| Curriculum | 1 | 2008 | 710 | 0.050 |
Why?
|
| Aerosols | 2 | 1994 | 66 | 0.050 |
Why?
|
| Sex Factors | 3 | 2012 | 1222 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 773 | 0.050 |
Why?
|
| Accreditation | 1 | 2021 | 83 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 261 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2016 | 5854 | 0.050 |
Why?
|
| Manometry | 1 | 2020 | 47 | 0.050 |
Why?
|
| Pentetic Acid | 2 | 1990 | 10 | 0.040 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 29 | 0.040 |
Why?
|
| Debridement | 2 | 2010 | 83 | 0.040 |
Why?
|
| Vital Capacity | 2 | 1990 | 74 | 0.040 |
Why?
|
| Bleomycin | 2 | 1989 | 151 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 1990 | 169 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 69 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1989 | 91 | 0.040 |
Why?
|
| Radionuclide Imaging | 3 | 1994 | 152 | 0.040 |
Why?
|
| Solubility | 1 | 2017 | 135 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1389 | 0.040 |
Why?
|
| Chromium Radioisotopes | 1 | 1997 | 5 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1240 | 0.040 |
Why?
|
| Edetic Acid | 1 | 1997 | 23 | 0.040 |
Why?
|
| Iohexol | 1 | 1997 | 20 | 0.040 |
Why?
|
| Causality | 1 | 2016 | 76 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 85 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2016 | 60 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1352 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 547 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1265 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 356 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 348 | 0.030 |
Why?
|
| Employment | 1 | 2015 | 67 | 0.030 |
Why?
|
| Terbutaline | 1 | 1994 | 6 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2015 | 76 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1985 | 5 | 0.030 |
Why?
|
| Peptides | 1 | 2017 | 798 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 1568 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1230 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2016 | 226 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 511 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 349 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 323 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 650 | 0.030 |
Why?
|
| Contrast Media | 1 | 1997 | 452 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1292 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2012 | 89 | 0.030 |
Why?
|
| Linear Models | 1 | 1994 | 654 | 0.030 |
Why?
|
| Vascular Fistula | 1 | 2012 | 28 | 0.030 |
Why?
|
| Vinblastine | 2 | 1989 | 46 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1709 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1788 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3289 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2012 | 87 | 0.020 |
Why?
|
| Apgar Score | 1 | 2011 | 44 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2011 | 68 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 568 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2012 | 177 | 0.020 |
Why?
|
| Organotechnetium Compounds | 1 | 1990 | 12 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1990 | 9 | 0.020 |
Why?
|
| Plants, Toxic | 1 | 1989 | 12 | 0.020 |
Why?
|
| Mucus | 1 | 1989 | 41 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2346 | 0.020 |
Why?
|
| Logistic Models | 2 | 2012 | 1741 | 0.020 |
Why?
|
| Pleurodesis | 1 | 2009 | 14 | 0.020 |
Why?
|
| Technetium | 1 | 1989 | 14 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2009 | 36 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 240 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 151 | 0.020 |
Why?
|
| Abscess | 1 | 2010 | 138 | 0.020 |
Why?
|
| Endoscopes | 1 | 2009 | 20 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 442 | 0.020 |
Why?
|
| Birth Weight | 1 | 2011 | 303 | 0.020 |
Why?
|
| Blastomycosis | 1 | 2008 | 7 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 1988 | 12 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1990 | 746 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 265 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 209 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 332 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1238 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 13 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 43 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2008 | 31 | 0.020 |
Why?
|
| PubMed | 1 | 2008 | 21 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2010 | 199 | 0.020 |
Why?
|
| Computer-Assisted Instruction | 1 | 2008 | 52 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 2787 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1988 | 139 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 449 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2007 | 140 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 189 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 1088 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 524 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 348 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 325 | 0.020 |
Why?
|
| Computers | 1 | 1986 | 68 | 0.020 |
Why?
|
| Mathematics | 1 | 1986 | 98 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2011 | 379 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 422 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1381 | 0.020 |
Why?
|
| Catheterization | 1 | 2006 | 236 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 473 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2008 | 358 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 621 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1988 | 1310 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3209 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1990 | 837 | 0.010 |
Why?
|
| Kidney | 1 | 1988 | 1329 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1437 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2779 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 2 | 1997 | 470 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1651 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 948 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 2919 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1776 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2370 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 7976 | 0.010 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1997 | 4 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 1997 | 6 | 0.010 |
Why?
|
| Lung Volume Measurements | 2 | 1987 | 67 | 0.010 |
Why?
|
| Urography | 1 | 1997 | 31 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 143 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 255 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 1677 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 13708 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1985 | 1139 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 417 | 0.010 |
Why?
|
| Educational Status | 1 | 1989 | 258 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1989 | 335 | 0.000 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1987 | 29 | 0.000 |
Why?
|
| Creatinine | 1 | 1988 | 377 | 0.000 |
Why?
|
| Child | 1 | 2006 | 23950 | 0.000 |
Why?
|
| Remission Induction | 1 | 1987 | 299 | 0.000 |
Why?
|
| Body Weight | 1 | 1990 | 963 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1990 | 1100 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1989 | 1144 | 0.000 |
Why?
|